Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand

Sponsor
Chulalongkorn University (Other)
Overall Status
Completed
CT.gov ID
NCT02000648
Collaborator
(none)
500
1
39
12.8

Study Details

Study Description

Brief Summary

Observation study of patients with chronic rhinitis or chronic urticaria in Thailand

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    All patients presenting with symptoms of chronic rhinitis for at least 12 consecutive or non-consecutive weeks per years or symptoms of chronic urticaria for at least 6 weeks will be asked to complete the case report forms asking for details of symptom characteristics, risk factors, personal habits, underlying diseases, and quality of life at the first visit. Investigation results, final diagnosis, and therapeutic interventions will also be recorded by the responsible allergist. On every follow-up appointment, patient symptoms, aggravating factors, medication use and side effects will be completed by patients. New findings, associated diseases, and prescriptions will be completed by allergist. The unfilled variables by patients will be asked in the following visit. Any "non-reported" variables those are unable to retrieve will be treated as missing data for data analysis. The estimated sample size is about 200 new cases per year.

    Patient demographic data, clinical presentations, and associated diseases will be reported. The association between clinical characteristics and quality of life will be analyzed. The relationship between clinical manifestations and therapeutic outcomes will be determined.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
    Actual Study Start Date :
    Jan 1, 2012
    Actual Primary Completion Date :
    Feb 1, 2015
    Actual Study Completion Date :
    Apr 1, 2015

    Arms and Interventions

    Arm Intervention/Treatment
    Patients diagnosed with chronic rhinitis or chronic urticaria

    Patients diagnosed with chronic rhinitis/urticaria and followed-up at Allergy Clinics, Chulalongkorn University

    Outcome Measures

    Primary Outcome Measures

    1. The recalcitrant symptoms of chronic rhinitis or chronic urticaria [Baseline and 2 months after treatment]

      The alteration of symptoms at 2 months compared to baseline. Patient's complaining symptoms will be graded as likert scale system (0, 1, 2, 3). Any symptoms at 2 months after treatment that decrease less than 25% from base line based on average likert scale will be defined as "recalcitrant".

    Secondary Outcome Measures

    1. The correlation between symptom severity and quality of life [At baseline]

      Pearson correlation between total nasal symptom score in patients with rhinitis or urticaria activity score in patients with chronic urticaria and 12-item short form survey version 2 (SF-12 v2) will be analyzed

    Other Outcome Measures

    1. Factors affecting therapeutic outcome (composite outcome measure) [At baseline]

      Multivariate analysis will be analyzed between age group, gender, allergic status, symptom severity and the magnitude of symptom alteration at 2 months after treatment

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    15 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Have symptoms of chronic rhinitis for at least 12 consecutive or non-consecutive weeks per year or symptoms of chronic urticaria for at least 6 weeks
    Exclusion Criteria:
    • Less than 15 years of age

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Faculty of Medicine, Chulalongkorn University Bangkok Thailand 10330

    Sponsors and Collaborators

    • Chulalongkorn University

    Investigators

    • Principal Investigator: Jettanong Klaewsongkram, MD, Chulalongkorn University

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Jettanong Klaewsongkram, Ass. Prof. Jettanong Klaewsongkram, MD., Chulalongkorn University
    ClinicalTrials.gov Identifier:
    NCT02000648
    Other Study ID Numbers:
    • Chula-ARC 001/13
    First Posted:
    Dec 4, 2013
    Last Update Posted:
    Feb 18, 2019
    Last Verified:
    Feb 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Jettanong Klaewsongkram, Ass. Prof. Jettanong Klaewsongkram, MD., Chulalongkorn University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 18, 2019